Skip to main content
Canature Health Technology Group Co.,Ltd logo

Canature Health Technology Group Co.,Ltd — Investor Relations & Filings

Ticker · 300272 ISIN · CNE1000018L9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,042 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300272

About Canature Health Technology Group Co.,Ltd

https://www.canature.com

Canature Health Technology Group Co.,Ltd. specializes in the research, development, and manufacturing of residential and commercial water treatment systems and components. The company’s core product portfolio includes multi-functional control valves, composite pressure tanks, water softeners, and whole-house water filtration systems. It also produces reverse osmosis units and specialized commercial purification equipment. Canature is recognized for its vertical integration, manufacturing key components in-house to ensure quality control and cost efficiency. The company provides comprehensive OEM and ODM services to a global clientele, adhering to international standards such as NSF and WQA. Its operations focus on delivering advanced water softening and purification solutions designed for diverse environmental conditions and user requirements.

Recent filings

Filing Released Lang Actions
第六届董事会第三十四次会议决议公告
Regulatory Filings Classification · 70% confidence The document is an announcement of the board of directors’ meeting resolutions in Chinese, detailing meeting attendance, the approval of a bank acquisition loan, and plans to convene the 2025 annual shareholders’ meeting. It does not contain financial statements or detailed report content, nor does it announce board member changes, dividends, or an actual report publication. It is thus a general regulatory announcement of corporate resolutions, best classified under Regulatory Filings (RNS).
2026-05-13 Chinese
关于公司向银行申请并购贷款并由全资子公司提供担保的公告
Capital/Financing Update Classification · 83% confidence The document is an announcement by the company’s board regarding the approval to apply for a merger and acquisition loan and the provision of guarantees by its wholly‐owned subsidiary. It details the loan amount, pledge and mortgage arrangements, and financing rationale. This is a financing activity update rather than a financial report, dividend notice, or governance document, fitting the Capital/Financing Update category.
2026-05-13 Chinese
关于召开2025年度股东会的通知
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a formal notice convening the 2025 Annual General Meeting, detailing meeting date, agenda items, voting proposals, proxy form and voting procedures. It serves as materials sent to shareholders to provide information and solicit votes, fitting the Proxy Solicitation & Information Statement category.
2026-05-13 Chinese
长江证券承销保荐有限公司关于开能健康科技集团股份有限公司向不特定对象发行可转换公司债券之持续督导保荐总结报告书
Regulatory Filings Classification · 85% confidence The document is a formal “持续督导保荐工作总结报告书” (continuous supervision sponsorship work summary report) prepared by the sponsor (Changjiang Securities) for the regulator and exchange, summarizing its regulatory oversight of a non-public convertible bond issuance. It is not an annual or interim financial report, earnings release, proxy/material for shareholder voting, nor an audit or ESG report. It is a specific compliance/regulatory submission under Chinese securities rules. Thus it falls under general Regulatory Filings (RNS).
2026-05-11 Chinese
关于设立子公司完成工商注册登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the establishment and registration of a wholly-owned subsidiary, including details such as company name, registration number, address, legal representative, registered capital, company type, establishment date, business scope, and licensing information. It is a formal disclosure by the board of directors ensuring the accuracy and completeness of the information. There is no financial data, no mention of financial results, no voting results, no management changes, no legal proceedings, no merger or acquisition activity, and no report publication. The document is an official announcement about a corporate structural event (setting up a subsidiary), which fits best under general regulatory announcements. It does not fit into any more specific category such as MANG (management changes) or CAP (capital/financing update) because it is about a new subsidiary registration rather than a financing event. Given the content and length (under 5,000 characters), it is not a full report but an announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-10-27 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the company's use of idle raised funds for cash management, including specifics on financial products purchased, approval procedures, risk analysis, and impact on the company. It includes tables of investment amounts, dates, and returns, as well as references to prior related announcements. The document is relatively short (3007 characters) and focuses on a specific financing activity rather than comprehensive financial results or management discussion. It is not an annual or interim report, nor a call transcript or AGM material. The content fits best with a Capital/Financing Update (CAP) as it details the company's financing activities related to cash management of idle raised funds.
2025-10-14 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.